Telithromycin (Ketek) for Respiratory Infections--Correction

The Medical Letter on Drugs and Therapeutics

FROM
ISSUE

1189

August 16, 2004

View Complete Issue Table of Contents 2019

Telithromycin (Ketek) for Respiratory Infections--Correction

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 2004 Aug 16;46(1189):66-8

Disclosures

Objective(s)

SUMMARY: Correction: In the table on page 66, the daily dosage of erythromycin should be 250-500 mg qid (not bid). Also, in the Canadian edition, the cost of telithromycin (Ketek) should be $65.52 (not $32.76).

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.